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Vitamin D deficiency has been associated with increased risk of tuberculosis (TB). Changes from a traditional to a Westernised diet among
Greenlanders have resulted in reduced serum vitamin D, leading to considerations of whether preventive vitamin D supplementation should be
introduced. The association between vitamin D status and TB was examined to assess the feasibility of vitamin D supplementation in Greenland.
This was examined in a case–control study involving seventy-two matched pairs of TB patients (cases) and controls aged 8–74 years. Cases were
diagnosed with TB during 2004–6 based on clinical findings in combination with either (1) positive Mycobacterium tuberculosis culture,
(2) characteristic X-ray abnormalities together with a positive tuberculin skin test or a positive interferon-g release assay or (3) characteristic
histology. Controls were individually matched on age (^5 years), sex and district. Serum 25-hydroxyvitamin D (25(OH)D) concentrations
were measured and OR of TB were the outcome. Compared with individuals with 25(OH)D concentrations between 75 and 140 nmol/l, individuals
with concentrations , 75 nmol/l (OR 6·5; 95 % CI 1·8, 23·5) or . 140 nmol/l (OR 6·5; 95 % CI 1·9, 22·2) had higher risks of active TB (P¼0·003;
adjustment for alcohol and ethnicity). Supplementing individuals with low vitamin D to normalise serum 25(OH)D concentrations was estimated to
result in a 29 % reduction in the number of TB cases. The study indicated that vitamin D supplementation may be beneficial to individuals with
insufficient vitamin D concentrations but may increase the risk of TB among individuals with normal or high concentrations.
Tuberculosis: Vitamin D: Odds ratios: Case–control studies: Greenland
Clinical tuberculosis (TB) is a major public health problem in
Greenland(1). After the Second World War, one of the highest
incidences (2300 per 100 000) in the world was found
here. Due to significant national efforts, the incidence of TB
in Greenland decreased substantially and reached in 1985
the lowest registered level of 25 per 100 000(1). Since then
the incidence has increased again to an average of seventy-
three cases per year corresponding to 131 per 100 000
during the period 1998–2007(2).
TB is caused by the intracellular pathogen Mycobacterium
tuberculosis which resides predominantly within macro-
phages. Paradoxically, macrophage activity is the first type
of defence against the M. tuberculosis infection(3). Vitamin
D is a modulator of macrophage function and can activate
host anti-mycobacterial activity. Its active metabolite, 1,25-
dihydroxyvitamin D (1,25(OH)2D), may improve the ability
of macrophages to inhibit the growth of mycobacteriae(4,5).
Hence, susceptibility to TB may be increased by vitamin D
deficiency(6,7). Accordingly, a recent systematic meta-analysis
concluded that low serum vitamin D concentrations are associ-
ated with higher risk of active TB(8). Thus, it is reasonable to
suggest that vitamin D supplementation to individuals exposed
to M. tuberculosis may be beneficial, especially in populations
where vitamin D synthesis in the skin is limited and where
vitamin D intake through the diet is scarce.
In Greenland exposure to sunlight is limited during winter and
vitamin D synthesis in the skin is therefore likely to be low
during this season. Moreover, during the last decades significant
cultural changes have occurred in Greenland(9), resulting in
the fact that many Greenlanders rely on a Westernised diet
low in vitamin D, contrasting to the Greenlandic traditional
diet consisting of vitamin D-rich fish and sea mammals(10,11).
It has been shown that changes from a Greenlandic to a
Westernised diet are associated with a reduced vitamin D
status(11). The present study was implemented to analyse the
association between vitamin D and active TB in Greenland
to assess the feasibility of population-based vitamin D
supplementation.
Subjects and methods
Study design and participants
We performed a case–control study including diagnosed TB
patients and matched controls in Greenland. The study was
part of a larger investigation which aimed at identifying risk
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factors of TB. Recruitment of participants took place during
2004–6 at thirteen district hospitals along the west, south
and east coasts of Greenland. A total of 216 adults were diag-
nosed with TB in 2004–6. Due to a rapid turnover of author-
ised staff and laboratory technicians to take care of blood
sampling at some district hospitals, it was not possible to
include all. Thus, a subsample of 155 (71 %) patients was
asked and accepted to participate. The selection was deter-
mined by the availability of staff to take care of the inclusion
procedures at the time of diagnosis and not by any patient
characteristics. For each patient it was intended to identify
four healthy sex- and age- (^5 years) matched population con-
trols from the same hospital district. In Greenland, all individ-
uals have a file at the district hospital containing identification
details from the Civil Registration System (CPR) register,
which contains unique details on all individuals in Denmark
and Greenland. Controls were chosen randomly among these
files. For four of the 155 patients no matched controls could
be identified, for two patients only two controls were ident-
ified, and for one patient three controls were identified.
Thus, a total of 599 controls were identified. All patients and
controls answered questions about ethnicity, weight and
height, smoking, alcohol and diet habits, and social status
(employment and income source). Individuals were defined
as Inuit if both parents and all grandparents were born in
Greenland. For the present study the intention was that all
patients and one of their four controls should donate a blood
sample for vitamin D (25-hydroxyvitamin D; 25(OH)D)
measurement. Among the patients, 148 had four identified
controls. The one control who provided a blood sample was
selected randomly among the four controls. However, for prac-
tical reasons it was not possible to obtain a blood sample from
all 148 patients and 148 controls. Successful measurement of
25(OH)D was obtained from seventy-two matched patient
and control pairs. Blood samples were collected at all times
of the year, and samples from pairs were collected within
1 week to avoid seasonal differences in vitamin D concentration.
The present study was conducted according to the
guidelines laid down in the Declaration of Helsinki and all
procedures were approved by The Commission for Scientific
Research in Greenland. Written informed consent was
obtained from all subjects.
Tuberculosis diagnosis
The inclusion criteria for patients were a TB diagnosis based on
clinical findings in combination with either (1) a positive
M. tuberculosis culture, (2) characteristic X-ray abnormalities
together with either a positive tuberculin skin test by the
Mantoux method or a positive interferon-g release assay
(Quantiferon Gold test) or (3) characteristic histology. The
Greenlandic TB registration did not differentiate between lung
and pleural TB; this is why all cases in the respiratory tract are
stated as pulmonary. Mycobacteriological analyses were
provided by the International Reference Laboratory of Myco-
bacteriology (Statens Serum Institut, Copenhagen, Denmark).
Measurement of vitamin D
The vitamin D status was assessed by measuring 25(OH)D as
previously described(12). We defined vitamin D insufficiency,
mild vitamin D deficiency, and severe vitamin D deficiency
as serum 25(OH)D concentrations of 50–75 nmol/l
(20–30 ng/ml), 25–49 nmol/l (10–19·6 ng/ml) and , 25
nmol/l (,10 ng/ml), respectively, according to previously
used definitions(13,14). Serum 25(OH)D concentrations of
76–140 nmol/l (30·4–56 ng/ml) and . 140 nmol/l (.56 ng/ml)
were characterised as normal and high, respectively.
Statistical analysis
The association between vitamin D and other potential risk
factors and TB were evaluated by unadjusted and adjusted
OR estimated by conditional logistic regression using
PROC LOGISTIC in SAS (SAS Institute, Inc., Cary, NC,
USA). Adjusted OR were adjusted for 25(OH)D, ethnicity
and alcohol. Adjustment variables were selected by a back-
ward elimination procedure. Due to particular focus on
vitamin D we also conducted analyses where only 25(OH)D
was in the model while adjusting for all other variables one
by one in separate analyses to test for whether these con-
founded the association between 25(OH)D and TB. Associ-
ations between 25(OH)D and other potential risk factors
were evaluated by x2 tests. In an additional analysis the
25(OH)D concentration in cases and controls was compared
using the non-parametric Wilcoxon test. Assuming a causal
effect of 25(OH)D on TB we estimated the effect of supple-
menting the low-25(OH)D group (,75 nmol/l) to normal
concentrations (76–140 nmol/l) using attributable risk. All
statistical analyses were performed with SAS version 9.2
software (SAS Institute, Inc.).
Results
Of the seventy-two patients, sixty-seven (93 %) were clinically
diagnosed with pulmonary TB. Of these, sixty-one patients
(91 %) were confirmed by M. tuberculosis culture and/or
sputum microscopy for acid-fast bacilli (twenty-one (31 %)
by cultures alone, four (6 %) by sputum microscopy alone,
and thirty-six (54 %) by both). Of the patients, five (7 %)
were diagnosed with extra-pulmonary TB. In one case (1 %)
the TB localisation was not registered. All cases of extra-
pulmonary TB were culture-confirmed. The mean time from
symptom debut to diagnosis was 116 (SD 119) d. The blood
sample was taken before treatment start in 29 %; among the
rest the mean time from treatment start to sample collection
was 18 (SD 25·6) d. Among controls with low, normal or
high 25(OH)D, 36, 54 and 75 % had eaten fish often
(P¼0·26), respectively, and 9, 25 and 38 %, respectively,
had eaten seal or whale often (P¼0·38). The respective num-
bers for patients were 36 %, 60 % and 57 % (P¼0·19) and
20 %, 35 % and 43 % (P¼0·26). Multivitamin tablets were
taken by one patient and two controls.
The mean age was 39 years and ranged between 8 and
69 years and 8 and 74 years for patients and controls, respec-
tively. Of the patients and controls, 89 and 74 % were Inuit.
Non-Inuits had a lower risk of TB (OR 0·1; 95 % CI 0·02,
0·5) compared with Inuits after adjusting for alcohol and
25(OH)D. Individuals with frequent (every day or between
one and six times per week) intake of alcohol had a higher
risk of TB (OR 3·9; 95 % CI 1·4, 11·2) compared with individ-
uals with a non-frequent (less than once per week) intake after
N. O. Nielsen et al.1488
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adjusting for 25(OH)D and ethnicity. BMI, smoking, intake
of fish, seal and whale meat, social status and concomitant
disease (thirteen individuals had hypertension, chronic obstruc-
tive lung disease, rheumatic disorders, epilepsy, mental
retardation, HIV, psychiatric disorders or eye problems)
were not associated with TB.
Fig. 1 shows the distribution of 25(OH)D. Mild deficiency
(25–49 nmol/l) was observed in 13 % of the patients and 1 %
of the controls, whereas insufficiency (50–75 nmol/l) was
found in 22 % of the patients and 15 % of the controls. No indi-
viduals had severe deficiency (,25 nmol/l). As there was only
one control with 25(OH)D , 50 nmol/l, the categories , 50
nmol/l and 50–75 nmol/l were merged into the one category.
Table 1 shows the distribution of patients and controls in
groups of low (,75 nmol/l), normal (76–140 nmol/l) and
high (.140 nmol/l) 25(OH)D concentrations together with
adjusted and unadjusted OR and 95 % CI. After adjusting
for ethnicity and alcohol, the association between 25(OH)D
and risk of TB was U-shaped, with an OR of 6·5 (95 %
CI 1·8, 23·5) among individuals with a 25(OH)D concen-
tration , 75 nmol/l, and an OR of 6·5 (95 % CI 1·9, 22·2)
among those with a concentration . 140 nmol/l, when com-
pared with individuals presenting concentrations between 76
and 140 nmol/l. The OR did not change considerably when
adjusting for ethnicity, BMI, smoking, alcohol, intake of
fish, seal and whale meat, social status or concomitant disease.
Restricting the analysis to Inuit pairs only (n 47) resulted in
a similar association pattern. We observed no associations
between 25(OH)D and any of the above variables. Analyses
with alternative cut-off points showed that the U-shaped
association pattern was not dependent on the chosen
categorisation.
An estimation of the effect of supplementing individuals
with low 25(OH)D (,75 nmol/l) to normal concentrations
(76–140 nmol/l) showed that the number of TB cases could
be reduced by 29 % when assuming a causal effect.
Discussion
The present study demonstrated that active TB was associated
with both low and high concentrations of vitamin D.
Low vitamin D concentrations being associated with a
higher risk of TB has been observed previously from different
parts of the world(8,13,15,16). The association may reflect a
causal relationship, but the direction cannot be determined
from the present design. However, given that the active meta-
bolite of vitamin D, 1,25(OH)2D, modulates macrophage
function and improves the ability of macrophages to inhibit
the growth of the mycobacteria(5,15), it is likely that low
vitamin D concentrations increase the susceptibility to TB(15).
Once an individual has become infected and developed active
TB, less exposure to sunlight(17) while confined more to
indoor life, and impaired appetite as a consequence of the
infection(18), may contribute to low 25(OH)D concentration
through reduced vitamin D synthesis in the skin and reduced
food intake.
An association between high serum 25(OH)D and TB in a
human population has, to our knowledge, not been described
previously. However, the phenomenon of high (and low)
25(OH)D has been associated with prostate cancer(19),
although other limits for low (#19 nmol/l) and high
($80 nmol/l) concentrations were used. The authors suggested
that high plasma and intracellular 25(OH)D stimulates intra-
cellular 24-hydroxylase which rapidly degrades 1,25(OH)2D
to the inactive 1,24,25-trihydroxyvitamin D resulting in low
concentrations of intracellular 1,25(OH)2D
(19,20) which,
again, results in increased proliferation of malignant cells.
This would result in increased prostate cancer risk.
A similar mechanism may apply in the present study.
High 25(OH)D concentration may lead to stimulation of
24-hydroxylase, which degrades 1,25(OH)2D and 25(OH)D
to their 24-hydroxylated inactive forms. This would
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Fig. 1. Distribution of 25-hydroxyvitamin D (25(OH)D) (nmol/l) among the
seventy-two tuberculosis (TB) patients ( ) and seventy-two controls (A). The
overall mean, median, standard deviation, minimum and maximum of
the serum 25(OH)D concentration were 108, 93, 60, 28 and 370 for the TB
patients and 110, 107, 38, 39 and 260 for the controls.
Table 1. Unadjusted and adjusted (for alcohol and ethnicity) risk for tuberculosis according to serum hydroxyvitamin D (25(OH)D)
(nmol/l) groups
(Odds ratios and 95 % confidence intervals)
Patients Controls Unadjusted Adjusted
25(OH)D (nmol/l) group n % n % OR 95 % CI P* OR 95 % CI P*
,75 25 35 12 17 5·3 1·9, 15·3 ,0·001 6·5 1·8, 23·5 0·003
76–140 26 36 52 72 1 Reference 1 Reference
.140 21 29 8 11 5·3† 1·9, 15·3 6·5† 1·9, 22·2
* Test for homogeneity according to 25(OH)D (nmol/l).
† Test for homogeneity between .140 nmol/l and 76–140 nmol/l: P¼0·02 (unadjusted) and P¼0·03 (adjusted).
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result in low 1,25(OH)2D concentrations and a probably
increased risk of TB. Alternatively, increased 1,25(OH)2D3
concentrations might lead to down-regulation of vitamin D
receptor expression resulting in defective vitamin D receptor
signalling as previously suggested(21).
We speculate that the association between high vitamin D
and TB could be confounded by n-3 fatty acids which are
largely gained from the same dietary sources as vitamin
D. Experimental studies(22,23), although presenting contra-
dictory findings, indicated that n-3 fatty acids impair the
immune response against M. tuberculosis. A recent study
showed that transgenic mice enriched in n-3 fatty acids were
more susceptible to M. tuberculosis than wild-type mice(22).
Thus, high levels of n-3 fatty acid may play a role in increas-
ing the risk of TB.
Vitamin A is another factor that might affect the risk of
TB. Individuals in the group of high vitamin D level may
also have an excessive level of vitamin A as a result of a
high intake of traditional food, possibly including liver
from sea mammals. Vitamin A supplementation in animal
studies has shown that a chronic excess of vitamin A may
depress cellular and humoral immune responses(24). Accord-
ingly, it has been hypothesised that vitamin A supplemen-
tation of children with adequate vitamin A stores might
cause a temporary immune dysregulation and lead to
increased susceptibility to infectious diseases(25). This con-
curs with the finding that vitamin A supplementation reduced
the incidence of acute lower respiratory tract infections in
children with poor nutritional status, but increased it in chil-
dren with normal nutritional status(24). Thus, concomitant
excess of vitamin A might have contributed to the high
risk of TB.
The U-shaped association between vitamin D and TB
suggests that population-based vitamin D supplementation
might not be suitable in Greenland, as supplementation of
non-deficient individuals may result in a vitamin D concen-
tration which could give a higher risk of TB. However,
when assuming a causal effect, our data indicate that sup-
plementation of deficient individuals would have beneficial
effects, as increasing the vitamin D concentration from
low to normal was estimated to result in a 29 % reduction
in the number of TB cases. Larger and prospectively
designed studies are needed to determine the direction of
a possible cause–effect relationship between vitamin D
and TB.
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